BIOGEN MA INC.

QALSODY

Manufacturer:

BIOGEN MA INC.

Qalsody HCPCS:

C9157

HCPCS Code Descriptor:

Injection, tofersen, 1 mg

Category:

C Code

Qalsody NDCs:

Primary Type:

Neurology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intrathecal

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Qalsody:

QALSODY is a neurology drug manufactured by Biogen and administered via the intrathecal route of administration. The C Code: C9157 is aligned to the drug QALSODY.

Qalsody is an injection used to treat ALS in adults caused by a genetic mutation in the SOD1 gene. Qalsody works by reducing the amount of a certain toxic protein in the body. The toxic protein is called the SOD1 protein, and it can cause damage to the motor neurons and worsen the symptoms of ALS. Qalsody can slow the progression of the disease, and can slow symptoms such as muscle weakness and loss of functions.

ACCESS PRICING AND MORE BY REGISTERING

C9157 Added Date:

October 1, 2023

C9157 Effective Date:

October 1, 2023

C9157 Termination Date:

December 31, 2023

We have not yet identified a manufacturer source of Qalsody billing and coding information.
Qalsody patient assistance information can be found through Biogen at the URL: https://www.qalsodyhcp.com/
QALSODY prescribing information can be found at the link below:
Information regarding QALSODY’s side effects can be found at MedlinePlus